glycocyamine has been researched along with Cardiovascular Diseases in 7 studies
glycocyamine: RN given refers to parent cpd; structure
guanidinoacetate : A monocarboxylic acid anion that is the conjugate base of guanidinoacetic acid, obtained by deprotonation of the carboxy group.
guanidinoacetic acid : The N-amidino derivative of glycine.
Cardiovascular Diseases: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (42.86) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hanff, E | 1 |
| Said, MY | 1 |
| Kayacelebi, AA | 1 |
| Post, A | 1 |
| Minovic, I | 1 |
| van den Berg, E | 1 |
| de Borst, MH | 1 |
| van Goor, H | 1 |
| Bakker, SJL | 1 |
| Tsikas, D | 1 |
| Ostojic, SM | 2 |
| Trivic, T | 1 |
| Drid, P | 1 |
| Stajer, V | 1 |
| Vranes, M | 2 |
| Loncar, D | 1 |
| Zenic, N | 1 |
| Sekulic, D | 1 |
| BORSOOK, H | 2 |
| BORSOOK, ME | 2 |
| GRAYBIEL, A | 1 |
| PATTERSON, CA | 1 |
| Andrade, F | 1 |
| Rodríguez-Soriano, J | 1 |
| Prieto, JA | 1 |
| Elorz, J | 1 |
| Aguirre, M | 1 |
| Ariceta, G | 1 |
| Martin, S | 1 |
| Sanjurjo, P | 1 |
| Aldámiz-Echevarría, L | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Effects of Medium-term Oral Guanidinoacetic Acid (GAA) Administration on Human Performance, Body Composition, and Metabolic Outcomes in Physically Active Men and Women[NCT01133899] | Phase 1/Phase 2 | 40 participants (Actual) | Interventional | 2010-03-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for glycocyamine and Cardiovascular Diseases
| Article | Year |
|---|---|
Effects of Guanidinoacetic Acid Loading on Biomarkers of Cardiometabolic Risk and Inflammation.
Topics: Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cholesterol, HDL; Dietary Supplements; Fema | 2018 |
6 other studies available for glycocyamine and Cardiovascular Diseases
| Article | Year |
|---|---|
High plasma guanidinoacetate-to-homoarginine ratio is associated with high all-cause and cardiovascular mortality rate in adult renal transplant recipients.
Topics: Adult; Aged; Cardiovascular Diseases; Cause of Death; Cross-Sectional Studies; Female; Follow-Up Stu | 2019 |
Guanidinoacetic Acid and Creatine are Associated with Cardiometabolic Risk Factors in Healthy Men and Women: A Cross-Sectional Study.
Topics: Adolescent; Adult; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Cholesterol; Chroma | 2018 |
The biochemical basis of betaine-glycocyamine therapy.
Topics: Betaine; Biochemical Phenomena; Cardiovascular Diseases; Creatine; Glycine; Humans | 1951 |
Treatment of cardiac decompensation with betaine and glycocyamine.
Topics: Betaine; Biochemical Phenomena; Cardiovascular Diseases; Creatine; Glycine; Heart Failure; Humans | 1951 |
Use of betaine and glycocyamine in the treatment of patients with heart disease: preliminary report.
Topics: Betaine; Cardiovascular Diseases; Creatine; Glycine; Heart Diseases; Humans | 1951 |
The arginine-creatine pathway is disturbed in children and adolescents with renal transplants.
Topics: Adolescent; Arginine; Cardiovascular Diseases; Case-Control Studies; Child; Creatine; Creatinine; Fe | 2008 |